The process of bringing new drug-eluting stents to market will they see the light of day?
Publication
, Journal Article
Holmes, DR; Patel, M
Published in: JACC Cardiovasc Interv
October 2008
Duke Scholars
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 2008
Volume
1
Issue
5
Start / End Page
533 / 534
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Thrombosis
- Sirolimus
- Severity of Illness Index
- Risk Assessment
- Research Design
- Randomized Controlled Trials as Topic
- Prosthesis Design
- Paclitaxel
Citation
APA
Chicago
ICMJE
MLA
NLM
Holmes, D. R., & Patel, M. (2008). The process of bringing new drug-eluting stents to market will they see the light of day? JACC Cardiovasc Interv, 1(5), 533–534. https://doi.org/10.1016/j.jcin.2008.08.001
Holmes, David R., and Manesh Patel. “The process of bringing new drug-eluting stents to market will they see the light of day?” JACC Cardiovasc Interv 1, no. 5 (October 2008): 533–34. https://doi.org/10.1016/j.jcin.2008.08.001.
Holmes DR, Patel M. The process of bringing new drug-eluting stents to market will they see the light of day? JACC Cardiovasc Interv. 2008 Oct;1(5):533–4.
Holmes, David R., and Manesh Patel. “The process of bringing new drug-eluting stents to market will they see the light of day?” JACC Cardiovasc Interv, vol. 1, no. 5, Oct. 2008, pp. 533–34. Pubmed, doi:10.1016/j.jcin.2008.08.001.
Holmes DR, Patel M. The process of bringing new drug-eluting stents to market will they see the light of day? JACC Cardiovasc Interv. 2008 Oct;1(5):533–534.
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
October 2008
Volume
1
Issue
5
Start / End Page
533 / 534
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Thrombosis
- Sirolimus
- Severity of Illness Index
- Risk Assessment
- Research Design
- Randomized Controlled Trials as Topic
- Prosthesis Design
- Paclitaxel